Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$910M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$449M |
| 5 |
Itaú Unibanco
ITUB
|
+$409M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.25B |
| 2 |
Canadian Natural Resources
CNQ
|
+$897M |
| 3 |
Enbridge
ENB
|
+$555M |
| 4 |
Suncor Energy
SU
|
+$483M |
| 5 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.5% |
| 2 | Healthcare | 8.63% |
| 3 | Financials | 8.23% |
| 4 | Consumer Discretionary | 7.29% |
| 5 | Industrials | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Zymeworks
ZYME
$1.67B
| $2.97M | ﹤0.01% |
328,078
+203,021
| +162% | +$1.77M |
|
|
TOUR
3477
Tuniu
TOUR
$55.6M
| $2.97M | ﹤0.01% |
158,588
-32,350
| -17% | -$648K |
|
|
GBIO
3478
DELISTED
Generation Bio
GBIO
| $2.97M | ﹤0.01% |
68,954
-11,246
| -14% | -$544K |
|
|
NETI
3479
DELISTED
Eneti Inc.
NETI
| $2.96M | ﹤0.01% |
317,090
+277,432
| +700% | +$2.77M |
|
3480
Biomea Fusion
BMEA
$91.3M
| $2.96M | ﹤0.01% |
95,542
+62,130
| +186% | +$772K |
|
3481
Invesco Semiconductors ETF
PSI
$2.5B
| $2.95M | ﹤0.01% |
71,619
+13,371
| +23% | +$517K |
|
3482
Bausch + Lomb
BLCO
$5.99B
| $2.94M | ﹤0.01% |
169,100
+133,249
| +372% | +$2.26M |
|
3483
Horizon Bancorp
HBNC
$1.04B
| $2.94M | ﹤0.01% |
265,846
+85,191
| +47% | +$1.22M |
|
3484
CALL
HP
HPQ
$27.5B
| $2.94M | ﹤0.01% |
100,000
+20,000
| +25% | +$574K |
|
3485
Viemed Healthcare
VMD
$371M
| $2.93M | ﹤0.01% |
303,341
+110,116
| +57% | +$960K |
|
3486
Park National Corp
PRK
$3.67B
| $2.93M | ﹤0.01% |
24,704
+5,804
| +31% | +$743K |
|
3487
FS KKR Capital
FSK
$3.44B
| $2.92M | ﹤0.01% |
158,040
-6,426
| -4% | -$122K |
|
3488
Vicor
VICR
$10.2B
| $2.91M | ﹤0.01% |
62,080
-66,013
| -52% | -$3.66M |
|
3489
UWM Holdings
UWMC
$434M
| $2.91M | ﹤0.01% |
592,460
+39,805
| +7% | +$175K |
|
|
EBIX
3490
DELISTED
Ebix Inc
EBIX
| $2.9M | ﹤0.01% |
219,861
+58,953
| +37% | +$1.03M |
|
3491
Ecovyst
ECVT
$1.14B
| $2.9M | ﹤0.01% |
262,127
-214,196
| -45% | -$2.21M |
|
3492
CALL
Ascendis Pharma A/S
ASND
$16.8B
| $2.89M | ﹤0.01% |
27,000
+20,400
| +309% | +$2.33M |
|
|
AVTA
3493
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.89M | ﹤0.01% |
109,868
+25,399
| +30% | +$690K |
|
3494
Universal Corp
UVV
$1.27B
| $2.89M | ﹤0.01% |
54,607
-29,864
| -35% | -$1.57M |
|
3495
PUT
Viatris
VTRS
$18.9B
| $2.89M | ﹤0.01% |
+300,000
| New | +$3.33M |
|
|
PGTI
3496
DELISTED
PGT, Inc.
PGTI
| $2.89M | ﹤0.01% |
114,916
-84,451
| -42% | -$1.79M |
|
3497
PUT
APA Corp
APA
$13.2B
| $2.88M | ﹤0.01% |
+80,000
| New | +$3.21M |
|
3498
Mission Produce
AVO
$1.17B
| $2.88M | ﹤0.01% |
259,539
+6,278
| +2% | +$73.3K |
|
|
PLYM
3499
DELISTED
Plymouth Industrial REIT
PLYM
| $2.88M | ﹤0.01% |
137,166
-177,430
| -56% | -$3.74M |
|
3500
Alta Equipment Group
ALTG
$245M
| $2.88M | ﹤0.01% |
181,707
-9,243
| -5% | -$155K |
|
Similar funds
Goldman Sachs's Q1 2023 Portfolio in Review
As of Q1 2023, Goldman Sachs held 6,534 positions worth $435B, up 6.7% from $408B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs's Q1 2023 filing shows 572 new, 2,273 increased, 2,515 reduced and 647 closed positions. Its largest new stake was GE HealthCare: 1,100,798 shares worth $90.3M. The largest sale was Alibaba, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Goldman Sachs's largest Q1 2023 buy was GE HealthCare: 1,100,798 shares worth $90.3M.
- Goldman Sachs added most to Microsoft in Q1 2023, an estimated $1.15B increase.
- Goldman Sachs's biggest Q1 2023 reduction was Alibaba, cutting an estimated $1.25B.
- Goldman Sachs fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $122M.
- Goldman Sachs's ten largest holdings make up 18% of its $435B portfolio in Q1 2023.
- Goldman Sachs opened 572 new positions and closed 647 in Q1 2023.
- Goldman Sachs's portfolio value rose 6.7% quarter-over-quarter to $435B.
Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.